Newsletter | May 12, 2022

05.12.22 -- Ensuring Supply Continuity In Biopharma

The Past And Future Of Managing Raw Material And Process Risks In Biomanufacturing

Is the biopharmaceutical supply chain fit for purpose given the growth of our industry? How far have we come in raw material supply management, and what still needs to be accomplished to ensure the delivery of safe and effective drugs?

High-Quality Resins Manufacturing During A Pandemic And Beyond

Explore this overview of the resin manufacturing process and how a reliable product discontinuation policy, commitment to business continuity management, and capacity expansion plans can help alleviate supply chain issues.

Business Continuity Program: Maintain Operations During Crises

Get insights into implementing a robust business continuity management program that can help secure supply, reduce risks, and maintain quality in manufacturing operations, from daily production through a crisis situation.

Supporting The Global Biopharma Industry With Single-Use Capacity Expansion

Explore Cytiva’s brand new single-use production facility in Wales, UK. This facility forms part of Cytiva and Pall Corporation’s >$1.5 billion investment in increased capacity to support the growing needs of the biopharmaceutical industry and to increase regional supply.

Request Information